Adagio Medical Inc.
Sponsor of FDA approved IDE iCLAS Clinical Study for patients with Persistent Atrial Fibrillation. Now enrolling!
Sponsor of FDA approved IDE iCLAS Clinical Study for patients with Persistent Atrial Fibrillation. Now enrolling!
Adagio Medical Inc. is a privately held company located in Laguna Hills, California, founded in 2011. The company is focused on developing innovative cryoablation technologies in the Health Care and Pharmaceutical industries. Their flagship product is the FDA approved IDE iCLAS Clinical Study for patients with Persistent Atrial Fibrillation, showcasing their commitment to addressing critical cardiac arrhythmias. Adagio Medical Inc. is currently enrolling patients for this groundbreaking study. The company recently secured a significant $9.50M Debt Financing investment on November 8, 2022. While the details of the investors behind this round are not disclosed, Adagio Medical Inc. is a Fjord Ventures portfolio company, which signifies a strong backing from reputable investors. For more information, interested parties can visit https://www.adagiomedical.com or contact [email protected]. Adagio Medical Inc.'s novel approach to cardiac arrhythmia treatment positions them as a promising player in the medical technology space with the potential to drive meaningful impact in patient care.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Debt Financing | $9.50M | - | 08 Nov 2022 | |
| Series E | $42.50M | 5 |
|
12 Nov 2020 |
| Venture Round | $7.00M | - | 13 Mar 2019 | |
| Seed Round | $4.14M | - | 19 Aug 2014 | |
| Seed Round | $3.00K | - | 25 Jun 2013 |
No recent news or press coverage available for Adagio Medical Inc..
We care about your data, and we'd love to use cookies make your experience better.
